"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","data_processing","platform_id","contact_name","contact_email","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","disease state:ch1","tissue:ch1"
"GSM3334304","microRNA profile of NPC1","GSM3334304","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","1","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334304/suppl/GSM3334304_20160607-s2-up-high100_NPC1.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334305","microRNA profile of NPC2","GSM3334305","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","2","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334305/suppl/GSM3334305_20160607-s2-down-high100_NPC2.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334306","microRNA profile of NPC3","GSM3334306","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","3","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334306/suppl/GSM3334306_20160607-s3-up-high100_NPC3.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334307","microRNA profile of NPC4","GSM3334307","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","4","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334307/suppl/GSM3334307_20160607-s3-down-high100_NPC4.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334308","microRNA profile of NPC5","GSM3334308","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","5","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334308/suppl/GSM3334308_20160607-s7-up-high100_NPC5.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334309","microRNA profile of NPC6","GSM3334309","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","6","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334309/suppl/GSM3334309_20160607-s7-down-high100_NPC6.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334310","microRNA profile of NPC7","GSM3334310","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","7","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334310/suppl/GSM3334310_20160607-s10-up-high100_NPC7.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334311","microRNA profile of NPC8","GSM3334311","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","8","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334311/suppl/GSM3334311_20160607-s21-up-high100_NPC8.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334312","microRNA profile of NPC9","GSM3334312","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","9","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334312/suppl/GSM3334312_20160607-s21-down-high100_NPC9.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334313","microRNA profile of NPC10","GSM3334313","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","10","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334313/suppl/GSM3334313_20160607-s24-up-high100_NPC10.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334314","microRNA profile of NPC11","GSM3334314","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","11","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334314/suppl/GSM3334314_20160607-s11-up-high100_NPC11.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334315","microRNA profile of NPC12","GSM3334315","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","12","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334315/suppl/GSM3334315_20160607-s11-down-high100_NPC12.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334316","microRNA profile of NPC13","GSM3334316","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","13","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334316/suppl/GSM3334316_20160624-s22-up-high100_NPC13.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334317","microRNA profile of NPC14","GSM3334317","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","14","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334317/suppl/GSM3334317_20160624-s22-down-high100_NPC14.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334318","microRNA profile of NPC15","GSM3334318","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","15","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334318/suppl/GSM3334318_20160624-s23-up-high100_NPC15.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334319","microRNA profile of NPC16","GSM3334319","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","16","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334319/suppl/GSM3334319_20160624-s23-down-high100_NPC16.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334320","microRNA profile of NPC17","GSM3334320","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","17","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334320/suppl/GSM3334320_20160624-s24-down-high100_NPC17.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334321","microRNA profile of NPC18","GSM3334321","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","18","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334321/suppl/GSM3334321_20160624-s17-up-high100_NPC18.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334322","microRNA profile of NPC19","GSM3334322","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","19","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334322/suppl/GSM3334322_20160624-s18-up-high100_NPC19.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334323","microRNA profile of NPC20","GSM3334323","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","20","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334323/suppl/GSM3334323_20160624-s18-down-high100_NPC20.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334324","microRNA profile of NPC21","GSM3334324","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","21","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334324/suppl/GSM3334324_20160624-s19-up-high100_NPC21.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334325","microRNA profile of NPC22","GSM3334325","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","22","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334325/suppl/GSM3334325_20160713-s2-up-high100_NPC22.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334326","microRNA profile of NPC23","GSM3334326","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","23","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334326/suppl/GSM3334326_20160713-s2-down-high100_NPC23.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334327","microRNA profile of NPC24","GSM3334327","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","24","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334327/suppl/GSM3334327_20160713-s3-down-high100_NPC24.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334328","microRNA profile of NPC25","GSM3334328","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","25","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334328/suppl/GSM3334328_20160624-s11-up-high100_NPC25.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334329","microRNA profile of NPC26","GSM3334329","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","26","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334329/suppl/GSM3334329_20160624-s11-down-high100_NPC26.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334330","microRNA profile of NPC27","GSM3334330","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","27","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334330/suppl/GSM3334330_20160624-s12-up-high100_NPC27.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334331","microRNA profile of NPC28","GSM3334331","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","28","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334331/suppl/GSM3334331_20160624-s12-down-high100_NPC28.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334332","microRNA profile of NPC29","GSM3334332","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","29","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334332/suppl/GSM3334332_20160624-s13-down-high100_NPC29.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334333","microRNA profile of NPC30","GSM3334333","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","30","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334333/suppl/GSM3334333_20160624-s14-up-high80_NPC30.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334334","microRNA profile of NPC31","GSM3334334","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","31","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334334/suppl/GSM3334334_20160624-s14-down-high100_NPC31.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334335","microRNA profile of NPC32","GSM3334335","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","32","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334335/suppl/GSM3334335_20160624-s15-up-high100_NPC32.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334336","microRNA profile of NPC33","GSM3334336","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","33","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334336/suppl/GSM3334336_20160624-s15-down-high100_NPC33.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334337","microRNA profile of NPC34","GSM3334337","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","34","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334337/suppl/GSM3334337_20160624-s16-up-high100_NPC34.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334338","microRNA profile of NPC35","GSM3334338","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","35","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334338/suppl/GSM3334338_20160713-s6-up-high100_NPC35.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334339","microRNA profile of NPC36","GSM3334339","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","36","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334339/suppl/GSM3334339_20160713-s6-down-high100_NPC36.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334340","microRNA profile of NPC37","GSM3334340","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","37","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334340/suppl/GSM3334340_20160713-s8-up-high100_NPC37.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334341","microRNA profile of NPC38","GSM3334341","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","38","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334341/suppl/GSM3334341_20160713-s9-up-high100_NPC38.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334342","microRNA profile of NPC39","GSM3334342","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","39","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334342/suppl/GSM3334342_20160713-s9-down-high100_NPC39.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334343","microRNA profile of NPC40","GSM3334343","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","40","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334343/suppl/GSM3334343_20160713-s11-up-high100_NPC40.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334344","microRNA profile of NPC41","GSM3334344","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","41","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334344/suppl/GSM3334344_20160713-s11-down-high100_NPC41.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334345","microRNA profile of NPC42","GSM3334345","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","42","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334345/suppl/GSM3334345_20160713-s12-up-high100_NPC42.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334346","microRNA profile of NPC43","GSM3334346","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","43","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334346/suppl/GSM3334346_20160713-s14-up-high100_NPC43.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334347","microRNA profile of NPC44","GSM3334347","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","44","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334347/suppl/GSM3334347_20160713-s14-down-high100_NPC44.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334348","microRNA profile of NPC45","GSM3334348","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","45","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334348/suppl/GSM3334348_20160713-s16-up-high100_NPC45.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334349","microRNA profile of NPC46","GSM3334349","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","46","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334349/suppl/GSM3334349_20160713-s17-up-high100_NPC46.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334350","microRNA profile of NPC47","GSM3334350","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","47","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334350/suppl/GSM3334350_20160713-s19-up-high100_NPC47.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334351","microRNA profile of NPC48","GSM3334351","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","48","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334351/suppl/GSM3334351_20160713-s19-down-high100_NPC48.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334352","microRNA profile of NPC49","GSM3334352","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","49","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334352/suppl/GSM3334352_20160713-s20-up-high100_NPC49.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334353","microRNA profile of NPC50","GSM3334353","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","50","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334353/suppl/GSM3334353_20160713-s20-down-high100_NPC50.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334354","microRNA profile of NPC51","GSM3334354","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","51","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334354/suppl/GSM3334354_20160713-s21-up-high100_NPC51.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334355","microRNA profile of NPC52","GSM3334355","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","52","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334355/suppl/GSM3334355_20160713-s22-up-high100_NPC52.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334356","microRNA profile of NPC53","GSM3334356","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","53","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334356/suppl/GSM3334356_20160713-s22-down-high100_NPC53.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334357","microRNA profile of NPC54","GSM3334357","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","54","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334357/suppl/GSM3334357_20160728-s15-up-high100_NPC54.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334358","microRNA profile of NPC55","GSM3334358","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","55","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334358/suppl/GSM3334358_20160728-s15-down-high100_NPC55.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334359","microRNA profile of NPC56","GSM3334359","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","56","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334359/suppl/GSM3334359_20160728-s16-up-high100_NPC56.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334360","microRNA profile of NPC57","GSM3334360","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","57","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334360/suppl/GSM3334360_20160728-s16-down-high100_NPC57.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334361","microRNA profile of NPC58","GSM3334361","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","58","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334361/suppl/GSM3334361_20160728-s17-up-high100_NPC58.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334362","microRNA profile of NPC59","GSM3334362","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","59","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334362/suppl/GSM3334362_20160728-s17-down-high100_NPC59.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334363","microRNA profile of NPC60","GSM3334363","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","60","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334363/suppl/GSM3334363_20160728-s18-up-high100_NPC60.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334364","microRNA profile of NPC61","GSM3334364","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","61","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334364/suppl/GSM3334364_20161125-s21-up-high100_NPC61.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334365","microRNA profile of NPC62","GSM3334365","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","62","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334365/suppl/GSM3334365_20161125-s21-down-high100_NPC62.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334366","microRNA profile of NPC63","GSM3334366","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","63","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334366/suppl/GSM3334366_20161125-s22-up-high100_NPC63.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334367","microRNA profile of NPC64","GSM3334367","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","64","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334367/suppl/GSM3334367_20161125-s22-down-high100_NPC64.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334368","microRNA profile of NPC65","GSM3334368","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","65","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334368/suppl/GSM3334368_20161125-s23-up-high100_NPC65.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334369","microRNA profile of NPC66","GSM3334369","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","66","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334369/suppl/GSM3334369_20161125-s23-down-high100_NPC66.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334370","microRNA profile of NPC67","GSM3334370","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","67","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334370/suppl/GSM3334370_20161125-s16-up-high100_NPC67.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334371","microRNA profile of NPC68","GSM3334371","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","68","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334371/suppl/GSM3334371_20161125-s16-down-high100_NPC68.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334372","microRNA profile of NPC69","GSM3334372","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","69","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334372/suppl/GSM3334372_20161125-s17-up-high100_NPC69.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334373","microRNA profile of NPC70","GSM3334373","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","70","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334373/suppl/GSM3334373_20161125-s8-up-high100_NPC70.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334374","microRNA profile of NPC71","GSM3334374","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","71","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334374/suppl/GSM3334374_20161125-s8-down-high100_NPC71.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334375","microRNA profile of NPC72","GSM3334375","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","72","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334375/suppl/GSM3334375_20161125-s10-up-high100_NPC72.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334376","microRNA profile of NPC73","GSM3334376","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","73","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334376/suppl/GSM3334376_20161125-s2-up-high100_NPC73.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334377","microRNA profile of NPC74","GSM3334377","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","74","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334377/suppl/GSM3334377_20161125-s10-down-high100_NPC74.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334378","microRNA profile of NPC75","GSM3334378","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","75","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334378/suppl/GSM3334378_20161125-s9-up-high100_NPC75.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334379","microRNA profile of NPC76","GSM3334379","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","76","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334379/suppl/GSM3334379_20161125-s9-down-high100_NPC76.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334380","microRNA profile of NPC77","GSM3334380","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","77","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334380/suppl/GSM3334380_20161125-s11-up-high100_NPC77.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334381","microRNA profile of NPC78","GSM3334381","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","78","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334381/suppl/GSM3334381_201611225-s2-down-high100_NPC78.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334382","microRNA profile of NPC79","GSM3334382","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","79","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334382/suppl/GSM3334382_20161125-s3-up-high100_NPC79.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334383","microRNA profile of NPC80","GSM3334383","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","80","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334383/suppl/GSM3334383_20161125-s4-up-high100_NPC80.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334384","microRNA profile of NPC81","GSM3334384","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","81","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334384/suppl/GSM3334384_20161125-s4-down-high100_NPC81.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334385","microRNA profile of NPC82","GSM3334385","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","82","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334385/suppl/GSM3334385_20161125-s6-up-high100_NPC82.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334386","microRNA profile of NPC83","GSM3334386","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","83","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334386/suppl/GSM3334386_20161125-s6-down-high100_NPC83.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334387","microRNA profile of NPC84","GSM3334387","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","84","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334387/suppl/GSM3334387_20161125-s7-up-high100_NPC84.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334388","microRNA profile of NPC85","GSM3334388","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","85","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334388/suppl/GSM3334388_20161125-s7-up-high100_NPC85.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334389","microRNA profile of NPC86","GSM3334389","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","86","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334389/suppl/GSM3334389_20161125-s34-up-high100_NPC86.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334390","microRNA profile of NPC87","GSM3334390","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","87","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334390/suppl/GSM3334390_20161125-s34-down-high100_NPC87.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334391","microRNA profile of NPC88","GSM3334391","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","88","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334391/suppl/GSM3334391_20161125-s35-up-high100_NPC88.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334392","microRNA profile of NPC89","GSM3334392","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","89","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334392/suppl/GSM3334392_20161125-s35-down-high100_NP89.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334393","microRNA profile of NPC90","GSM3334393","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","90","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334393/suppl/GSM3334393_20161125-s36-up-high100_NPC90.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334394","microRNA profile of NPC91","GSM3334394","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","91","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334394/suppl/GSM3334394_20161125-s36-down-high100_NPC91.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334395","microRNA profile of NPC92","GSM3334395","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","92","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334395/suppl/GSM3334395_20161125-s32-down-high100_NPC92.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334396","microRNA profile of NPC93","GSM3334396","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","93","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334396/suppl/GSM3334396_20161125-s28-down-high100_NPC93.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334397","microRNA profile of NPC94","GSM3334397","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","94","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334397/suppl/GSM3334397_20161125-s29-up-high100_NPC94.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334398","microRNA profile of NPC95","GSM3334398","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","95","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334398/suppl/GSM3334398_20161125-s29-down-high100_NPC95.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334399","microRNA profile of NPC96","GSM3334399","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","96","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334399/suppl/GSM3334399_20170303-s9-up-high100_NPC96.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334400","microRNA profile of NPC97","GSM3334400","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","97","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334400/suppl/GSM3334400_20170303-s9-down-high100_NPC97.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334401","microRNA profile of NPC98","GSM3334401","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","98","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334401/suppl/GSM3334401_20170303-s10-up-high100_NPC98.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334402","microRNA profile of NPC99","GSM3334402","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","99","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334402/suppl/GSM3334402_20170303-s10-down-high100_NPC99.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334403","microRNA profile of NPC100","GSM3334403","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","100","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334403/suppl/GSM3334403_20170303-s11-up-high100_NPC100.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334404","microRNA profile of NPC101","GSM3334404","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","101","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334404/suppl/GSM3334404_20170303-s11-down-high100_NPC101.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334405","microRNA profile of NPC102","GSM3334405","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","102","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334405/suppl/GSM3334405_20170303-s12-up-high100_NPC102.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334406","microRNA profile of NPC103","GSM3334406","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","103","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334406/suppl/GSM3334406_20170303-s12-down-high100_NPC103.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334407","microRNA profile of NPC104","GSM3334407","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","104","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334407/suppl/GSM3334407_20170303-s18-up-high100_NPC104.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334408","microRNA profile of NPC105","GSM3334408","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","105","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334408/suppl/GSM3334408_20170303-s18-down-high100_NPC105.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334409","microRNA profile of NPC106","GSM3334409","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","106","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334409/suppl/GSM3334409_20170303-s19-up-high100_NPC106.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334410","microRNA profile of NPC107","GSM3334410","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","107","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334410/suppl/GSM3334410_20170303-s19-down-high100_NPC107.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334411","microRNA profile of NPC108","GSM3334411","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","108","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334411/suppl/GSM3334411_20170303-s20-high100_NPC108.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334412","microRNA profile of NPC109","GSM3334412","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","109","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334412/suppl/GSM3334412_20170303-s20-down-high100_NPC109.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334413","microRNA profile of NPC110","GSM3334413","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","110","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334413/suppl/GSM3334413_20170303-s21-up-high100_NPC110.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334414","microRNA profile of NPC111","GSM3334414","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","111","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334414/suppl/GSM3334414_20170303-s21-down-high100_NPC111.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334415","microRNA profile of NPC112","GSM3334415","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","112","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334415/suppl/GSM3334415_20170303-s22-up-high100_NPC112.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334416","microRNA profile of NPC113","GSM3334416","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","113","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334416/suppl/GSM3334416_20170303-s22-down-high100-NPC113.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334417","microRNA profile of NPC114","GSM3334417","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","114","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334417/suppl/GSM3334417_20170303-s28-up-high100-NPC114.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334418","microRNA profile of NPC115","GSM3334418","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","115","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334418/suppl/GSM3334418_20170303-s28-down-high100_NPC115.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334419","microRNA profile of NPC116","GSM3334419","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","116","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334419/suppl/GSM3334419_20170303-s29-up-high100_NPC116.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334420","microRNA profile of NPC117","GSM3334420","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","117","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334420/suppl/GSM3334420_20161125-s24-up-high100-NPC117.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334421","microRNA profile of NPC118","GSM3334421","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","118","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334421/suppl/GSM3334421_20161125-s24-down-high100_NPC118.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334422","microRNA profile of NPC119","GSM3334422","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","119","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334422/suppl/GSM3334422_20161125-s25-up-high100_NPC119.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334423","microRNA profile of NPC120","GSM3334423","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","120","Homo sapiens","disease state: nasopharyngeal carcinoma","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334423/suppl/GSM3334423_20161125-s25-down-high100_NPC120.gpr.gz","1856","nasopharyngeal carcinoma","whole blood"
"GSM3334424","microRNA profile of NC1","GSM3334424","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","121","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334424/suppl/GSM3334424_20161125-s20-up-high100_NC1.gpr.gz","1856","normal control","whole blood"
"GSM3334425","microRNA profile of NC2","GSM3334425","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","122","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334425/suppl/GSM3334425_20161125-s20-down-high100_NC2.gpr.gz","1856","normal control","whole blood"
"GSM3334426","microRNA profile of NC3","GSM3334426","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","123","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334426/suppl/GSM3334426_20161125-s18-up-high100_NC3.gpr.gz","1856","normal control","whole blood"
"GSM3334427","microRNA profile of NC4","GSM3334427","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","124","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334427/suppl/GSM3334427_20161125-s18-down-high100_NC4.gpr.gz","1856","normal control","whole blood"
"GSM3334428","microRNA profile of NC5","GSM3334428","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","125","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334428/suppl/GSM3334428_20161125-s19-up-high100_NC5.gpr.gz","1856","normal control","whole blood"
"GSM3334429","microRNA profile of NC6","GSM3334429","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","126","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334429/suppl/GSM3334429_20161125-s19-down-high100_NC6.gpr.gz","1856","normal control","whole blood"
"GSM3334430","microRNA profile of NC7","GSM3334430","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","127","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334430/suppl/GSM3334430_20161125-s12-up-high100_NC7.gpr.gz","1856","normal control","whole blood"
"GSM3334431","microRNA profile of NC8","GSM3334431","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","128","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334431/suppl/GSM3334431_20161125-s12-down-high100_NC8.gpr.gz","1856","normal control","whole blood"
"GSM3334432","microRNA profile of NC9","GSM3334432","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","129","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334432/suppl/GSM3334432_20161125-s13-up-high100_NC9.gpr.gz","1856","normal control","whole blood"
"GSM3334433","microRNA profile of NC10","GSM3334433","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","130","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334433/suppl/GSM3334433_20161125-s13-down-high100_NC10.gpr.gz","1856","normal control","whole blood"
"GSM3334434","microRNA profile of NC11","GSM3334434","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","131","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334434/suppl/GSM3334434_20161125-s11-down-high100_NC11.gpr.gz","1856","normal control","whole blood"
"GSM3334435","microRNA profile of NC12","GSM3334435","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","132","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334435/suppl/GSM3334435_20161125-s37-up-high100_NC12.gpr.gz","1856","normal control","whole blood"
"GSM3334436","microRNA profile of NC13","GSM3334436","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","133","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334436/suppl/GSM3334436_20161125-s37-down-high100_NC13.gpr.gz","1856","normal control","whole blood"
"GSM3334437","microRNA profile of NC14","GSM3334437","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","134","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334437/suppl/GSM3334437_20161125-s39-up-high100_NC14.gpr.gz","1856","normal control","whole blood"
"GSM3334438","microRNA profile of NC15","GSM3334438","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","135","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334438/suppl/GSM3334438_20161125-s39-down-high100_NC15.gpr.gz","1856","normal control","whole blood"
"GSM3334439","microRNA profile of NC16","GSM3334439","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","136","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334439/suppl/GSM3334439_20161125-s37-up-high100_NC16.gpr.gz","1856","normal control","whole blood"
"GSM3334440","microRNA profile of NC17","GSM3334440","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","137","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334440/suppl/GSM3334440_201611252-s37-down-high100_NC17.gpr.gz","1856","normal control","whole blood"
"GSM3334441","microRNA profile of NC18","GSM3334441","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","138","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334441/suppl/GSM3334441_20161125-s27-up-high100_NC18.gpr.gz","1856","normal control","whole blood"
"GSM3334442","microRNA profile of NC19","GSM3334442","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","139","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334442/suppl/GSM3334442_20161125-s27-down-high100_NC19.gpr.gz","1856","normal control","whole blood"
"GSM3334443","microRNA profile of NC20","GSM3334443","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","140","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334443/suppl/GSM3334443_20161125-s28-up-high100_NC20.gpr.gz","1856","normal control","whole blood"
"GSM3334444","microRNA profile of NC21","GSM3334444","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","141","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334444/suppl/GSM3334444_20170303-s33-up-high100_NC21.gpr.gz","1856","normal control","whole blood"
"GSM3334445","microRNA profile of NC22","GSM3334445","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","142","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334445/suppl/GSM3334445_20170303-s33-down-high100_NC22.gpr.gz","1856","normal control","whole blood"
"GSM3334446","microRNA profile of NC23","GSM3334446","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","143","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334446/suppl/GSM3334446_20170303-s34-up-high100_NC23.gpr.gz","1856","normal control","whole blood"
"GSM3334447","microRNA profile of NC24","GSM3334447","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","144","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334447/suppl/GSM3334447_20170303-s17-down-high100_NC24.gpr.gz","1856","normal control","whole blood"
"GSM3334448","microRNA profile of NC25","GSM3334448","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","145","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334448/suppl/GSM3334448_20170303-s27-down-high100_NC25.gpr.gz","1856","normal control","whole blood"
"GSM3334449","microRNA profile of NC26","GSM3334449","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","146","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334449/suppl/GSM3334449_20170303-s34-down-high100_NC26.gpr.gz","1856","normal control","whole blood"
"GSM3334450","microRNA profile of NC27","GSM3334450","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","147","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334450/suppl/GSM3334450_20170303-s35-up-high100_NC27.gpr.gz","1856","normal control","whole blood"
"GSM3334451","microRNA profile of NC28","GSM3334451","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","148","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334451/suppl/GSM3334451_20170303-s35-down-high100_NC28.gpr.gz","1856","normal control","whole blood"
"GSM3334452","microRNA profile of NC29","GSM3334452","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","149","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334452/suppl/GSM3334452_20170303-s36-up-high100_NC29.gpr.gz","1856","normal control","whole blood"
"GSM3334453","microRNA profile of NC30","GSM3334453","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","150","Homo sapiens","disease state: normal control","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334453/suppl/GSM3334453_20170303-s36-down-high100_NC30.gpr.gz","1856","normal control","whole blood"
"GSM3334454","microRNA profile of HNT1","GSM3334454","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","151","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334454/suppl/GSM3334454_20161125-s30-up-high100_HNT1.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334455","microRNA profile of HNT2","GSM3334455","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","152","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334455/suppl/GSM3334455_20161125-s30-down-high100_HNT2.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334456","microRNA profile of HNT3","GSM3334456","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","153","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334456/suppl/GSM3334456_20161125-s31-up-high100_HNT3.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334457","microRNA profile of HNT4","GSM3334457","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","154","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334457/suppl/GSM3334457_20161125-s31-down-high100_HNT4.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334458","microRNA profile of HNT5","GSM3334458","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","155","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334458/suppl/GSM3334458_20161125-s32-up-high100_HNT5.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334459","microRNA profile of HNT6","GSM3334459","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","156","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334459/suppl/GSM3334459_20170303-s29-down-high100_HNT6.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334460","microRNA profile of HNT7","GSM3334460","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","157","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334460/suppl/GSM3334460_20161125-s26-up-high100_HNT7.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334461","microRNA profile of HNT8","GSM3334461","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","158","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334461/suppl/GSM3334461_20161125-s26-down-high100_HNT8.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334462","microRNA profile of HNT9","GSM3334462","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","159","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334462/suppl/GSM3334462_20170303-s30-up-high100_HNT9.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334463","microRNA profile of HNT10","GSM3334463","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","160","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334463/suppl/GSM3334463_20170303-s37-up-high100-HNT10.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334464","microRNA profile of HNT11","GSM3334464","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","161","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334464/suppl/GSM3334464_20170303-s37-down-high100_HNT11.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334465","microRNA profile of HNT12","GSM3334465","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","162","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334465/suppl/GSM3334465_20170303-s13-up-high100_HNT12.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334466","microRNA profile of HNT13","GSM3334466","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","163","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334466/suppl/GSM3334466_20170303-s38-up-high100_HNT13.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334467","microRNA profile of HNT14","GSM3334467","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","164","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334467/suppl/GSM3334467_20170303-s13-down-high100_HNT14.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334468","microRNA profile of HNT15","GSM3334468","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","165","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334468/suppl/GSM3334468_20170303-s14-up-high100_HNT15.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334469","microRNA profile of HNT16","GSM3334469","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","166","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334469/suppl/GSM3334469_20170303-s23-up-high100_HNT16.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334470","microRNA profile of HNT17","GSM3334470","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","167","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334470/suppl/GSM3334470_20170303-s23-down-high100_HNT17.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334471","microRNA profile of HNT18","GSM3334471","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","168","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334471/suppl/GSM3334471_20170303-s14-down-high100_HNT18.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334472","microRNA profile of HNT19","GSM3334472","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","169","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334472/suppl/GSM3334472_20170303-s15-up-high100_HNT19.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334473","microRNA profile of HNT20","GSM3334473","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","170","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334473/suppl/GSM3334473_20170303-s15-down-high100_HNT20.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334474","microRNA profile of HNT21","GSM3334474","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","171","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334474/suppl/GSM3334474_20170303-s17-up-high100-HNT21.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334475","microRNA profile of HNT22","GSM3334475","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","172","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334475/suppl/GSM3334475_20170303-s39-down-high100_HNT22.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334476","microRNA profile of HNT23","GSM3334476","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","173","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334476/suppl/GSM3334476_20170303-s40-up-high100_HNT23.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334477","microRNA profile of HNT24","GSM3334477","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","174","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334477/suppl/GSM3334477_20170303-s27-up-high100_HNT24.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334478","microRNA profile of HNT25","GSM3334478","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","175","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334478/suppl/GSM3334478_20170303-s30-down-high100_HNT25.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334479","microRNA profile of HNT26","GSM3334479","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","176","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334479/suppl/GSM3334479_20170303-s31-up-high100_HNT26.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334480","microRNA profile of HNT27","GSM3334480","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","177","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334480/suppl/GSM3334480_20170303-s31-down-high100_HNT27.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334481","microRNA profile of HNT28","GSM3334481","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","178","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334481/suppl/GSM3334481_20170303-s32-up-high100_HNT28.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334482","microRNA profile of HNT29","GSM3334482","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","179","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334482/suppl/GSM3334482_20170303-s32-down-high100_HNT29.gpr.gz","1856","head-neck tumor","whole blood"
"GSM3334483","microRNA profile of HNT30","GSM3334483","Public on Jun 16 2019","Aug 15 2018","Jun 16 2019","RNA","1","180","Homo sapiens","disease state: head-neck tumor","tissue: whole blood","total RNA","Total RNA was extracted using RNA Purification Kit (Norgen Biotek, Thorold, Ontario, Canada).","pCp-DY647","2.5 μg of total RNA of nasopharyngeal carcinoma, head-neck tumours and normal controls whole blood was employed with 100 nmol/L of pCp-DY647 (Dharmacon, Lafayette, CO, USA) and 15 Units of T4 RNA ligase (USB, Cleveland, Oh, USA) in a total reaction volume of 20 μL at 16°C overnight.","9606","The labeled RNAs were hybridized to the array with a 1× hybridization solution (5× Denhart’s solution, 0.5% SDS, 5× SSC) in a Hybridization Chamber (Corning Inc, Corning, NY, USA) at 46°C for 12 to 16 hours.","Scanned in a LuxScanTM -10K Scanner (capitalBio Inc., Beijing, China).","Quantile normalization across multiple arrays, log 2 transformation of expression levels, EXPression Analyzer and DisplayER (EXPANDER) version 4.1 was used.","GPL19888","Mei-Yin,,Zhang","zhangmy@sysucc.org.cn","State Key Laboratory of Oncology in South China","Sun Yat-sen University Cancer Center","651 Dongfeng East Road","Guangzhou","Guangdong","510060","China","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM3334nnn/GSM3334483/suppl/GSM3334483_20170303-s40-down-high100_HNT30.gpr.gz","1856","head-neck tumor","whole blood"
